 Maria Nagel
Concepts (348)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 3, Human | 68 | 2023 | 389 | 19.300 |
Why?
| | Herpes Zoster | 42 | 2023 | 336 | 12.060 |
Why?
| | Temporal Arteries | 17 | 2021 | 47 | 6.350 |
Why?
| | Giant Cell Arteritis | 13 | 2021 | 47 | 5.790 |
Why?
| | DNA, Viral | 13 | 2021 | 356 | 3.460 |
Why?
| | Cerebral Arteries | 8 | 2021 | 56 | 2.910 |
Why?
| | Encephalitis, Varicella Zoster | 9 | 2016 | 20 | 2.820 |
Why?
| | Amyloid beta-Peptides | 6 | 2022 | 200 | 2.790 |
Why?
| | Varicella Zoster Virus Infection | 5 | 2021 | 21 | 2.600 |
Why?
| | Virus Diseases | 8 | 2022 | 198 | 2.520 |
Why?
| | Stroke | 10 | 2023 | 1047 | 2.420 |
Why?
| | Chickenpox | 11 | 2022 | 100 | 2.270 |
Why?
| | Islet Amyloid Polypeptide | 3 | 2021 | 47 | 2.180 |
Why?
| | Antibodies, Viral | 10 | 2020 | 542 | 2.110 |
Why?
| | Herpesviridae Infections | 6 | 2021 | 142 | 2.100 |
Why?
| | Varicellovirus | 6 | 2022 | 28 | 1.870 |
Why?
| | Astrocytes | 4 | 2020 | 177 | 1.840 |
Why?
| | Adventitia | 5 | 2021 | 39 | 1.710 |
Why?
| | Antiviral Agents | 14 | 2022 | 654 | 1.660 |
Why?
| | Antigens, Viral | 6 | 2021 | 181 | 1.580 |
Why?
| | Vascular Diseases | 6 | 2014 | 241 | 1.540 |
Why?
| | Virus Activation | 5 | 2020 | 80 | 1.470 |
Why?
| | Gene Expression Regulation, Viral | 4 | 2019 | 84 | 1.470 |
Why?
| | Fibroblasts | 5 | 2021 | 842 | 1.450 |
Why?
| | Arteritis | 2 | 2021 | 27 | 1.440 |
Why?
| | Virus Latency | 7 | 2019 | 84 | 1.400 |
Why?
| | Adrenal Glands | 2 | 2021 | 72 | 1.330 |
Why?
| | Herpesvirus 1, Human | 6 | 2016 | 81 | 1.270 |
Why?
| | Cerebrovascular Disorders | 3 | 2021 | 86 | 1.190 |
Why?
| | Exanthema | 6 | 2022 | 77 | 1.170 |
Why?
| | Peptide Fragments | 2 | 2021 | 702 | 1.130 |
Why?
| | B7-H1 Antigen | 2 | 2019 | 144 | 1.130 |
Why?
| | Ganglia | 4 | 2019 | 30 | 0.980 |
Why?
| | Host-Pathogen Interactions | 4 | 2020 | 300 | 0.940 |
Why?
| | Vasculitis, Central Nervous System | 3 | 2016 | 17 | 0.940 |
Why?
| | Substance P | 2 | 2020 | 44 | 0.920 |
Why?
| | Humans | 83 | 2023 | 118974 | 0.920 |
Why?
| | Neuralgia, Postherpetic | 7 | 2014 | 45 | 0.910 |
Why?
| | Optic Neuropathy, Ischemic | 5 | 2015 | 29 | 0.900 |
Why?
| | Nervous System Diseases | 4 | 2016 | 261 | 0.890 |
Why?
| | Cerebral Amyloid Angiopathy | 1 | 2021 | 10 | 0.780 |
Why?
| | Cell Death | 1 | 2022 | 339 | 0.750 |
Why?
| | Protein Aggregation, Pathological | 1 | 2020 | 17 | 0.740 |
Why?
| | Amyloid | 1 | 2021 | 87 | 0.740 |
Why?
| | Immunoglobulin G | 6 | 2013 | 788 | 0.730 |
Why?
| | Antigens, CD | 2 | 2019 | 460 | 0.730 |
Why?
| | Vascular Remodeling | 1 | 2021 | 152 | 0.730 |
Why?
| | Central Nervous System Infections | 1 | 2020 | 39 | 0.720 |
Why?
| | Aged, 80 and over | 17 | 2020 | 6561 | 0.720 |
Why?
| | Herpes Zoster Ophthalmicus | 2 | 2016 | 5 | 0.710 |
Why?
| | Corneal Keratocytes | 1 | 2019 | 8 | 0.690 |
Why?
| | Meningitis | 1 | 2020 | 74 | 0.680 |
Why?
| | Epithelium, Corneal | 1 | 2019 | 40 | 0.680 |
Why?
| | Receptors, Neurokinin-1 | 1 | 2018 | 12 | 0.670 |
Why?
| | Matrix Metalloproteinases | 2 | 2019 | 90 | 0.670 |
Why?
| | Cerebral Arterial Diseases | 2 | 2015 | 43 | 0.660 |
Why?
| | Aged | 24 | 2021 | 19657 | 0.660 |
Why?
| | Pseudopodia | 1 | 2018 | 20 | 0.660 |
Why?
| | Middle Aged | 26 | 2021 | 27617 | 0.650 |
Why?
| | Cadherins | 1 | 2019 | 186 | 0.640 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2018 | 113 | 0.640 |
Why?
| | Myofibroblasts | 1 | 2019 | 120 | 0.640 |
Why?
| | Cells, Cultured | 8 | 2021 | 4077 | 0.630 |
Why?
| | Asymptomatic Diseases | 2 | 2016 | 81 | 0.630 |
Why?
| | Saliva | 3 | 2016 | 188 | 0.590 |
Why?
| | Male | 36 | 2023 | 57801 | 0.590 |
Why?
| | Burning Mouth Syndrome | 1 | 2016 | 5 | 0.580 |
Why?
| | SUNCT Syndrome | 1 | 2016 | 1 | 0.570 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1597 | 0.570 |
Why?
| | Spinal Cord | 2 | 2018 | 367 | 0.570 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2019 | 702 | 0.550 |
Why?
| | Interleukin-6 | 1 | 2019 | 688 | 0.540 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2019 | 982 | 0.530 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2016 | 177 | 0.530 |
Why?
| | Vasculitis | 2 | 2015 | 75 | 0.520 |
Why?
| | Tunica Intima | 2 | 2012 | 78 | 0.510 |
Why?
| | Myxovirus Resistance Proteins | 1 | 2014 | 8 | 0.510 |
Why?
| | Acyclovir | 4 | 2020 | 105 | 0.500 |
Why?
| | Stellate Ganglion | 1 | 2014 | 4 | 0.500 |
Why?
| | Ganglia, Sympathetic | 1 | 2014 | 18 | 0.490 |
Why?
| | Herpesvirus 2, Human | 1 | 2014 | 28 | 0.490 |
Why?
| | STAT1 Transcription Factor | 1 | 2014 | 69 | 0.490 |
Why?
| | Steroids | 1 | 2015 | 153 | 0.490 |
Why?
| | Hippocampus | 1 | 2018 | 735 | 0.480 |
Why?
| | Zoster Sine Herpete | 2 | 2012 | 3 | 0.480 |
Why?
| | Cytokines | 2 | 2019 | 1900 | 0.480 |
Why?
| | Transcription, Genetic | 3 | 2019 | 1323 | 0.470 |
Why?
| | Female | 31 | 2023 | 61565 | 0.470 |
Why?
| | Aorta | 1 | 2016 | 367 | 0.470 |
Why?
| | Transcriptome | 3 | 2021 | 756 | 0.460 |
Why?
| | Leukocyte Common Antigens | 1 | 2013 | 76 | 0.450 |
Why?
| | Middle Cerebral Artery | 1 | 2012 | 30 | 0.450 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2013 | 48 | 0.440 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2445 | 0.420 |
Why?
| | Open Reading Frames | 4 | 2018 | 121 | 0.380 |
Why?
| | RNA, Messenger | 4 | 2020 | 2657 | 0.380 |
Why?
| | Gene Expression | 3 | 2020 | 1489 | 0.380 |
Why?
| | Cell Movement | 3 | 2019 | 896 | 0.370 |
Why?
| | RNA, Viral | 4 | 2012 | 572 | 0.370 |
Why?
| | B-Cell Activating Factor | 1 | 2009 | 18 | 0.350 |
Why?
| | Pemphigus | 1 | 2009 | 8 | 0.350 |
Why?
| | Antigens, CD20 | 1 | 2009 | 28 | 0.350 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 409 | 0.340 |
Why?
| | Viral Proteins | 5 | 2018 | 296 | 0.340 |
Why?
| | Primary Cell Culture | 2 | 2022 | 155 | 0.320 |
Why?
| | Inflammation | 5 | 2022 | 2566 | 0.320 |
Why?
| | Trigeminal Ganglion | 3 | 2013 | 22 | 0.320 |
Why?
| | Macaca mulatta | 4 | 2022 | 153 | 0.310 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2019 | 984 | 0.300 |
Why?
| | Alzheimer Disease | 2 | 2023 | 513 | 0.300 |
Why?
| | Animals | 17 | 2022 | 33381 | 0.290 |
Why?
| | Endothelium, Vascular | 1 | 2013 | 907 | 0.290 |
Why?
| | Retinal Necrosis Syndrome, Acute | 3 | 2013 | 9 | 0.270 |
Why?
| | Adult | 14 | 2020 | 31512 | 0.270 |
Why?
| | Leukocytes | 2 | 2018 | 290 | 0.250 |
Why?
| | Lymphocyte Depletion | 2 | 2019 | 119 | 0.250 |
Why?
| | Virus Replication | 3 | 2022 | 405 | 0.240 |
Why?
| | Diabetes Mellitus | 1 | 2012 | 942 | 0.230 |
Why?
| | Brain | 5 | 2016 | 2490 | 0.230 |
Why?
| | Magnetic Resonance Imaging | 7 | 2016 | 3174 | 0.230 |
Why?
| | Herpes Simplex | 2 | 2016 | 90 | 0.230 |
Why?
| | B-Lymphocytes | 3 | 2013 | 770 | 0.220 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1284 | 0.210 |
Why?
| | Azadirachta | 1 | 2022 | 4 | 0.210 |
Why?
| | Adrenal Cortex | 1 | 2022 | 34 | 0.210 |
Why?
| | Biopsy | 2 | 2016 | 1079 | 0.210 |
Why?
| | Exosomes | 1 | 2023 | 92 | 0.210 |
Why?
| | Risk Factors | 5 | 2021 | 9000 | 0.210 |
Why?
| | Paraffin Embedding | 1 | 2021 | 22 | 0.210 |
Why?
| | Tissue Fixation | 1 | 2021 | 32 | 0.210 |
Why?
| | Formaldehyde | 1 | 2021 | 50 | 0.200 |
Why?
| | Immunosuppressive Agents | 2 | 2020 | 681 | 0.200 |
Why?
| | Electrophoresis, Capillary | 2 | 2013 | 22 | 0.200 |
Why?
| | Viral Envelope Proteins | 2 | 2020 | 80 | 0.200 |
Why?
| | Macaca fascicularis | 1 | 2021 | 53 | 0.200 |
Why?
| | Autoantibodies | 1 | 2009 | 1335 | 0.200 |
Why?
| | Histological Techniques | 1 | 2021 | 43 | 0.200 |
Why?
| | Plasma | 1 | 2023 | 224 | 0.200 |
Why?
| | Cerebral Angiography | 2 | 2012 | 116 | 0.200 |
Why?
| | Skin | 2 | 2019 | 657 | 0.190 |
Why?
| | DNA, Complementary | 1 | 2021 | 268 | 0.190 |
Why?
| | Cell Line | 4 | 2020 | 2707 | 0.190 |
Why?
| | Neuronal Outgrowth | 1 | 2020 | 10 | 0.190 |
Why?
| | Whole-Body Irradiation | 1 | 2020 | 72 | 0.190 |
Why?
| | TRPM Cation Channels | 1 | 2021 | 68 | 0.190 |
Why?
| | Olfactory Receptor Neurons | 1 | 2021 | 67 | 0.180 |
Why?
| | Interleukins | 1 | 2022 | 242 | 0.180 |
Why?
| | Prevalence | 3 | 2015 | 2326 | 0.180 |
Why?
| | Intracellular Space | 1 | 2020 | 69 | 0.180 |
Why?
| | Anti-Inflammatory Agents | 2 | 2014 | 465 | 0.180 |
Why?
| | Claudin-1 | 1 | 2019 | 17 | 0.180 |
Why?
| | Thrombosis | 1 | 2023 | 309 | 0.180 |
Why?
| | Extracellular Space | 1 | 2020 | 127 | 0.180 |
Why?
| | Protein Aggregates | 1 | 2020 | 70 | 0.180 |
Why?
| | Tacrolimus | 1 | 2020 | 151 | 0.180 |
Why?
| | Culture Media, Conditioned | 1 | 2019 | 112 | 0.180 |
Why?
| | Case-Control Studies | 2 | 2020 | 3171 | 0.170 |
Why?
| | Diabetic Neuropathies | 1 | 2020 | 78 | 0.170 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 1 | 2019 | 14 | 0.170 |
Why?
| | Spinal Cord Diseases | 2 | 2010 | 39 | 0.170 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2019 | 55 | 0.170 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 1 | 2019 | 29 | 0.170 |
Why?
| | Neurokinin-1 Receptor Antagonists | 1 | 2018 | 9 | 0.170 |
Why?
| | Spiro Compounds | 1 | 2018 | 10 | 0.170 |
Why?
| | Electrochemical Techniques | 1 | 2019 | 39 | 0.170 |
Why?
| | CTLA-4 Antigen | 1 | 2019 | 86 | 0.170 |
Why?
| | Diagnosis, Differential | 3 | 2013 | 1384 | 0.170 |
Why?
| | Coculture Techniques | 1 | 2019 | 208 | 0.160 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2018 | 87 | 0.160 |
Why?
| | Monkey Diseases | 1 | 2018 | 21 | 0.160 |
Why?
| | DNA | 3 | 2021 | 1388 | 0.160 |
Why?
| | Motor Neurons | 1 | 2020 | 213 | 0.160 |
Why?
| | Risk | 1 | 2020 | 853 | 0.150 |
Why?
| | Herpes Zoster Vaccine | 2 | 2011 | 159 | 0.150 |
Why?
| | Protein Isoforms | 1 | 2018 | 345 | 0.150 |
Why?
| | Aortic Diseases | 1 | 2018 | 94 | 0.150 |
Why?
| | Fatal Outcome | 2 | 2015 | 287 | 0.150 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 197 | 0.150 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1171 | 0.150 |
Why?
| | Aortitis | 1 | 2016 | 7 | 0.140 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 521 | 0.140 |
Why?
| | Virology | 2 | 2013 | 20 | 0.140 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 509 | 0.140 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 395 | 0.140 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2014 | 333 | 0.140 |
Why?
| | Macrophages | 2 | 2013 | 1324 | 0.140 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2015 | 23 | 0.140 |
Why?
| | Matrix Metalloproteinase 3 | 1 | 2015 | 22 | 0.140 |
Why?
| | Neuroglia | 1 | 2016 | 157 | 0.140 |
Why?
| | Eye Infections, Viral | 1 | 2015 | 7 | 0.130 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2015 | 56 | 0.130 |
Why?
| | Oxygen | 1 | 2020 | 854 | 0.130 |
Why?
| | Histocytochemistry | 1 | 2015 | 82 | 0.130 |
Why?
| | Neurons | 2 | 2016 | 1345 | 0.130 |
Why?
| | Functional Laterality | 1 | 2016 | 208 | 0.130 |
Why?
| | Pheochromocytoma | 1 | 2016 | 54 | 0.130 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2015 | 127 | 0.130 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2016 | 81 | 0.130 |
Why?
| | STAT2 Transcription Factor | 1 | 2014 | 3 | 0.130 |
Why?
| | Vision Disorders | 2 | 2012 | 135 | 0.130 |
Why?
| | Nanoparticles | 1 | 2018 | 325 | 0.120 |
Why?
| | Insulin Resistance | 1 | 2023 | 1180 | 0.120 |
Why?
| | Internationality | 1 | 2015 | 152 | 0.120 |
Why?
| | Interferon-beta | 1 | 2014 | 82 | 0.120 |
Why?
| | Down-Regulation | 1 | 2016 | 627 | 0.120 |
Why?
| | Medulla Oblongata | 1 | 2013 | 33 | 0.120 |
Why?
| | Risk Assessment | 1 | 2023 | 3057 | 0.120 |
Why?
| | Fluorometry | 1 | 2013 | 20 | 0.120 |
Why?
| | Pons | 1 | 2013 | 31 | 0.120 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 59 | 0.120 |
Why?
| | Age Factors | 2 | 2014 | 2995 | 0.120 |
Why?
| | Polyethylene Glycols | 1 | 2018 | 578 | 0.110 |
Why?
| | Cell Culture Techniques | 1 | 2015 | 356 | 0.110 |
Why?
| | Intracranial Aneurysm | 1 | 2014 | 99 | 0.110 |
Why?
| | Myelitis | 1 | 2014 | 88 | 0.110 |
Why?
| | Interferon-alpha | 1 | 2014 | 191 | 0.110 |
Why?
| | Dementia, Multi-Infarct | 1 | 2012 | 3 | 0.110 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1012 | 0.110 |
Why?
| | Protein Transport | 1 | 2014 | 412 | 0.110 |
Why?
| | Blood Vessels | 1 | 2014 | 187 | 0.110 |
Why?
| | Optic Nerve | 1 | 2012 | 65 | 0.110 |
Why?
| | RNA | 1 | 2019 | 833 | 0.110 |
Why?
| | Methylprednisolone | 1 | 2012 | 84 | 0.110 |
Why?
| | Facial Paralysis | 1 | 2011 | 17 | 0.100 |
Why?
| | Immunohistochemistry | 1 | 2016 | 1691 | 0.100 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2011 | 55 | 0.100 |
Why?
| | Cell Proliferation | 1 | 2019 | 2275 | 0.100 |
Why?
| | Apoptosis | 2 | 2019 | 2484 | 0.100 |
Why?
| | Fetus | 1 | 2015 | 690 | 0.100 |
Why?
| | Hyperplasia | 1 | 2011 | 170 | 0.100 |
Why?
| | Cerebrospinal Fluid | 1 | 2011 | 93 | 0.090 |
Why?
| | RNA Stability | 1 | 2011 | 97 | 0.090 |
Why?
| | Herpes Zoster Oticus | 1 | 2010 | 5 | 0.090 |
Why?
| | Biomarkers | 1 | 2020 | 3588 | 0.090 |
Why?
| | Comorbidity | 1 | 2015 | 1527 | 0.090 |
Why?
| | Myosin Heavy Chains | 1 | 2011 | 192 | 0.090 |
Why?
| | Phosphorylation | 1 | 2014 | 1633 | 0.090 |
Why?
| | Immunocompromised Host | 1 | 2011 | 200 | 0.090 |
Why?
| | In Vitro Techniques | 1 | 2012 | 1094 | 0.090 |
Why?
| | Cranial Nerve Diseases | 1 | 2010 | 42 | 0.090 |
Why?
| | Neural Stem Cells | 1 | 2011 | 120 | 0.090 |
Why?
| | Receptors, CCR1 | 1 | 2009 | 2 | 0.090 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2011 | 236 | 0.090 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2009 | 3 | 0.090 |
Why?
| | Longitudinal Studies | 1 | 2016 | 2513 | 0.090 |
Why?
| | Lung | 3 | 2019 | 3664 | 0.090 |
Why?
| | Actins | 1 | 2011 | 404 | 0.080 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 82 | 0.080 |
Why?
| | History, 21st Century | 1 | 2009 | 170 | 0.080 |
Why?
| | Laboratories | 1 | 2009 | 97 | 0.080 |
Why?
| | History, 20th Century | 1 | 2009 | 281 | 0.080 |
Why?
| | Spectrometry, Fluorescence | 1 | 2009 | 173 | 0.080 |
Why?
| | Rituximab | 1 | 2009 | 155 | 0.080 |
Why?
| | Adolescent | 3 | 2013 | 18480 | 0.080 |
Why?
| | DNA Primers | 1 | 2009 | 533 | 0.080 |
Why?
| | Chickenpox Vaccine | 1 | 2007 | 69 | 0.070 |
Why?
| | Neutrophils | 1 | 2012 | 1233 | 0.070 |
Why?
| | Pain | 1 | 2012 | 735 | 0.070 |
Why?
| | Base Sequence | 1 | 2010 | 2159 | 0.070 |
Why?
| | Antidepressive Agents | 1 | 2008 | 189 | 0.070 |
Why?
| | Spinal Cord Ischemia | 1 | 2007 | 78 | 0.070 |
Why?
| | Incidence | 1 | 2013 | 2424 | 0.070 |
Why?
| | Registries | 1 | 2014 | 1810 | 0.070 |
Why?
| | Predictive Value of Tests | 2 | 2011 | 1868 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2010 | 2871 | 0.070 |
Why?
| | Analgesics | 1 | 2007 | 159 | 0.070 |
Why?
| | Substance-Related Disorders | 1 | 2014 | 971 | 0.070 |
Why?
| | Time Factors | 3 | 2014 | 6412 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 4552 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1774 | 0.060 |
Why?
| | Disease Progression | 4 | 2014 | 2490 | 0.060 |
Why?
| | Recurrence | 2 | 2021 | 975 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1795 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2011 | 1753 | 0.060 |
Why?
| | Presenilin-1 | 1 | 2022 | 29 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 2436 | 0.060 |
Why?
| | MicroRNAs | 1 | 2009 | 637 | 0.060 |
Why?
| | Limonins | 1 | 2022 | 2 | 0.050 |
Why?
| | Plant Bark | 1 | 2022 | 11 | 0.050 |
Why?
| | Fructose | 1 | 2023 | 204 | 0.050 |
Why?
| | Olfactory Bulb | 1 | 2022 | 125 | 0.050 |
Why?
| | Signal Transduction | 1 | 2014 | 4709 | 0.050 |
Why?
| | Olfactory Mucosa | 1 | 2021 | 59 | 0.050 |
Why?
| | Analgesics, Opioid | 1 | 2008 | 794 | 0.050 |
Why?
| | Plant Extracts | 1 | 2022 | 165 | 0.050 |
Why?
| | Uric Acid | 1 | 2023 | 354 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 220 | 0.040 |
Why?
| | Neuroimaging | 1 | 2021 | 256 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 226 | 0.040 |
Why?
| | Mice | 3 | 2022 | 15520 | 0.040 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2020 | 185 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2018 | 334 | 0.040 |
Why?
| | Mice, SCID | 1 | 2018 | 333 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 953 | 0.040 |
Why?
| | Gene Transfer Techniques | 1 | 2018 | 154 | 0.040 |
Why?
| | Plasmids | 1 | 2018 | 355 | 0.040 |
Why?
| | Action Potentials | 1 | 2020 | 420 | 0.040 |
Why?
| | Proteomics | 1 | 2022 | 876 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2019 | 3730 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2019 | 455 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2025 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2019 | 442 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1206 | 0.030 |
Why?
| | Young Adult | 1 | 2010 | 10793 | 0.030 |
Why?
| | Mitochondria | 1 | 2020 | 786 | 0.030 |
Why?
| | Ultrasonography, Doppler | 1 | 2014 | 104 | 0.030 |
Why?
| | Visual Acuity | 1 | 2015 | 272 | 0.030 |
Why?
| | Basal Ganglia Cerebrovascular Disease | 1 | 2012 | 2 | 0.030 |
Why?
| | Vertebrobasilar Insufficiency | 1 | 2012 | 7 | 0.030 |
Why?
| | Apraxias | 1 | 2012 | 9 | 0.030 |
Why?
| | Pupil Disorders | 1 | 2012 | 5 | 0.030 |
Why?
| | Dysarthria | 1 | 2012 | 9 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 381 | 0.030 |
Why?
| | Postmortem Changes | 1 | 2012 | 16 | 0.030 |
Why?
| | Valine | 1 | 2012 | 77 | 0.030 |
Why?
| | Immediate-Early Proteins | 1 | 2012 | 55 | 0.030 |
Why?
| | Cyclophosphamide | 1 | 2012 | 222 | 0.030 |
Why?
| | Gait Disorders, Neurologic | 1 | 2012 | 40 | 0.030 |
Why?
| | Thalamus | 1 | 2012 | 80 | 0.030 |
Why?
| | Prednisone | 1 | 2012 | 235 | 0.030 |
Why?
| | Thiouridine | 1 | 2011 | 2 | 0.030 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 2011 | 18 | 0.030 |
Why?
| | Phosphonoacetic Acid | 1 | 2011 | 10 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 4908 | 0.020 |
Why?
| | Memory Disorders | 1 | 2012 | 168 | 0.020 |
Why?
| | Subarachnoid Space | 1 | 2011 | 8 | 0.020 |
Why?
| | Half-Life | 1 | 2011 | 147 | 0.020 |
Why?
| | Magnetic Resonance Angiography | 1 | 2012 | 210 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 410 | 0.020 |
Why?
| | Alphaherpesvirinae | 1 | 2009 | 2 | 0.020 |
Why?
| | Vero Cells | 1 | 2009 | 69 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2012 | 965 | 0.020 |
Why?
| | Acute Disease | 1 | 2011 | 940 | 0.020 |
Why?
| | Immunization | 1 | 2011 | 412 | 0.020 |
Why?
| | Child | 2 | 2021 | 19129 | 0.020 |
Why?
| | Recovery of Function | 1 | 2012 | 604 | 0.020 |
Why?
| | Infant | 1 | 2021 | 8293 | 0.020 |
Why?
| | HeLa Cells | 1 | 2009 | 583 | 0.020 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2007 | 32 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 9491 | 0.020 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2007 | 90 | 0.020 |
Why?
| | Paralysis | 1 | 2007 | 67 | 0.020 |
Why?
| | Chronic Disease | 1 | 2012 | 1636 | 0.020 |
Why?
| | Treatment Failure | 1 | 2007 | 341 | 0.020 |
Why?
| | Arteries | 1 | 2007 | 250 | 0.020 |
Why?
| | Neoplasms | 1 | 2018 | 2179 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 2851 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 3457 | 0.010 |
Why?
|
|
Nagel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|